Clinical Trials Browser

Phase 2 × Digestive System Neoplasms × apatinib × Clear all

NCT06099821 2023-10-26

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Phase 2 Recruiting

Gastrointestinal

Digestive System Neoplasms

NCT03271255 2019-01-23

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Colorectal Neoplasms